US Patent Issued to Bristol-Myers Squibb on Oct. 7 for "Triazole carboxylic acids as LPA antagonists" (New Jersey, California, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,057, issued on Oct. 7, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Triazole carboxylic acids as LPA antagonists" was invented by Peter Tai Wah Cheng (Princeton, N.J.), Hao Zhang (Belle Mead, N.J.), Robert F. Kaltenbach III (Holland, Pa.), Jun Li (Pittsburgh), Jun Shi (San Diego), Shiwei Tao (Hillsborough, N.J.) and Yan Shi (Flourtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of Formula (I), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors."

The p...